Drug Trial Radar · NCT02105493
Nitroglycerin Prevents Radial Artery Occlusion
Last checked: Nov 19, 2026Latest source record: Apr 7, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,706
Actual
Start
Oct 2013
Primary completion
Feb 2014
Study completion Mar 2014
Sponsor
- Lead sponsor
- National Cardiovascular Center Harapan Kita Hospital IndonesiaAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Apr 7, 2014
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (investigator)
- Primary purpose
- Prevention
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Trans-radial approach (TRA) has becoming popular and widely adopted over the last decade. However, radial artery occlusion (RAO) continues to be one of the limitation of trans-radial access and potentially limits the radial artery as an access site in the future. Several strategies have been used to decrease the incidence of RAO including the use of anticoagulation, maintenance of patency during hemostasis, or shortening the duration of compression. Currently, there is no data whether vasoactive pharmacological therapy such as nitroglycerin administered intra-arterially at the end of the procedure may reduce the incidence of RAO. It is hypothesized that the addition of nitroglycerin (nitric oxide donor) at the end of a TRA procedure may reduce the incidence of RAO.
Conditions
- Injury of Radial Artery
Interventions
500 microgram of NitroglycerinDrug
500 microgram of Nitroglycerin (in 5 mL saline) given intra-arterially through the sheath at the end of transradial procedure
Saline 5 mLDrug
Saline 5 mL given intra-arterially through the sheath at the end of transradial procedure
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of radial artery occlusion as confirmed by absence of antegrade flow in vascular high resolution ultrasoundTime frame: One Day After the Index Procedure
Locations
1 site in 1 country. Site status is shown where the registry gives one.
National Cardiovascular Center Harapan Kita
Jakarta, Jakarta Special Capital Region, Indonesia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.